Compare JBSS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBSS | OPK |
|---|---|---|
| Founded | 1959 | 2006 |
| Country | United States | United States |
| Employees | 1900 | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 913.0M | 921.2M |
| IPO Year | 1994 | 2011 |
| Metric | JBSS | OPK |
|---|---|---|
| Price | $77.78 | $1.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $109.00 | $1.60 |
| AVG Volume (30 Days) | 83.1K | ★ 2.1M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.55 | N/A |
| Revenue | ★ $1,107,246,000.00 | $606,879,000.00 |
| Revenue This Year | $5.58 | N/A |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | $17.25 | ★ N/A |
| Revenue Growth | ★ 3.79 | N/A |
| 52 Week Low | $59.07 | $0.98 |
| 52 Week High | $85.15 | $1.60 |
| Indicator | JBSS | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 43.67 |
| Support Level | $74.24 | $1.12 |
| Resistance Level | $84.04 | $1.25 |
| Average True Range (ATR) | 2.82 | 0.04 |
| MACD | -0.28 | -0.01 |
| Stochastic Oscillator | 31.39 | 55.85 |
John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.